Skip to main content Accessibility help
×
Home

Criteria for Evaluating Improvement in Schizophrenia in Psychopharmacological Research (With Special Reference to Gamma Endorphin Fragments)

  • Rahul Manchanda (a1), Steven R. Hirsch (a2) and Thomas R. E. Barnes (a2)

Abstract

A review of treatment trials with DTγE revealed widely discrepant results. Relevant variables were the variety of measures employed for monitoring psychotic symptoms, and the different criteria used to judge the degree of improvement. The authors suggest a uniform outcome criterion for early trials of new treatments, which would generate more consistent and comparable results between studies, and give a stronger indication of the value of the treatment under test. When the data from the various treatment trials of DTγE were re analysed, applying a uniform outcome criterion of improvement of a change of 80% or more on rating-scale score, the results were more consistent than would have been suspected from the original reports.

Copyright

Corresponding author

Charing Cross and Westminster Medical School, Fulham Palace Road, London W6 8RF

References

Hide All
De Weid, D., Kovacs, G. L., Bohus, B., Van Ree, J. M. & Greven, H. M. (1978a) Neuroleptic activity of the neuropeptide-LPH 62–77 (des-tyr-γ-endorphin: DTγE). European Journal of Pharmacology, 49, 427436.
De Weid, D., Van Ree, J. M., Verhoeven, W. M. A. & Van Praag, H. M. (1978b). Endorphins and schizophrenia. Abstract No. 430, IInd World Congress of Biological Psychiatry, 31 August-6 September 1978, Barcelona. New York: Plenum.
Endicott, , Spitzer, R. L., Fleiss, J. L. & Cohen, J. (1976) The global assessment scale, a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766771.
Emrich, H. M., Zandig, M., Kissling, W., Dirlich, G., Zerrsen, D. V. & Herz, A. (1980) Des-tyrosyl-–endorphin in schizophrenia, a double blind trial in 13 patients. Pharmakopsychiatrie, 13, 290298.
Gispen, W. H., Ormond, D., Ten Haaf, J. & De Weid, D. (1980) Modulation of ACTH induced grooming by (Des-tyr)–endorphin and haloperidol. European Journal of Pharmacology, 63, 203207.
Honigfeld, G. & Klett, C. J. (1965) The nurses' observation scale for inpatient evaluation. Journal of Clinical Psychology, 21, 6571.
Krawiecka, M., Goldberg, D. & Vaughn, M. (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299308.
Loeber, J., Verhoef, J., Burbech, J. P. H. & Van Ree, J. M. (1979) Endorphins and related peptides in human cerebrospinal fluid. Acta Endocrinology Copenhagen, 91, (suppl. 225), 74.
Manchanda, R. & Hirsch, S. R. (1981) (Des-tyr1)–endorphin in the treatment of schizophrenia. Psychological Medicine, 11, 401404.
Manchanda, R. & Hirsch, S. R. (1982) (Des-tyr1)–endorphin for schizophrenia – critical review. International Pharmacopsychiatry, 17, 147152.
Manchanda, R. & Hirsch, S. R. (1986) (Des-tyr1)–endorphin in the treatment of depression: double blind placebo controlled trial. Human Psychopharmacology, 1, 99102.
Meltzer, H. Y., Busch, D. A., Tricou, B. J. & Robertson, A. (1982) Effect of (des-tyr)-gamma-endorphin in schizophrenia. Psychiatry Research, 6, 313326.
Overall, L. J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799812.
Spitzer, R. L. & Endicott, J. (1977) Schedule for Affective Disorders and Schizophrenia (SADS-C) (3rd edn). New York: New York State Psychiatric Institute.
Tamminga, C. A., Tighe, P. J., Chase, T. N., de Fraites, G. & Scaffer, M. H. (1981) Des-tyrosine-–endorphin administration in chronic schizophrenics – a preliminary report. Archives of General Psychiatry, 38, 167168.
Verhoef, J., Loeber, J. G., Burbach, J. P. H., Gispen, W. H., Witter, A. & De Weid, D. (1980) -endorphin, –endorphin and their dcs-tyrosine fragments in rat pituitary and brain tissue. Life Sciences, 26, 851859.
Verhoeven, W. M. A., Van Praag, H. M., Van Ree, J. M. & De Weid, D. (1979) Improvement of schizophrenic patients by treatment with des-tyr–endorphin. Archives of General Psychiatry, 36, 294302.
Verhoeven, W. M. A., Van Ree, J. M., Van Bentum, A. H., De Weid, D., Van Praag, H. M. (1982) Antipsychotic properties of des-enkephalin–endorphin in treatment of schizophrenic patients. Archives of General Psychiatry, 39, 648654.
Verhoeven, W. M. A., Westenberg, H. G. M., Gerritsen, A. W., Van Praag, H. M., Thijssen, J. H. H., Schwarz, F., Van Ree, J. M. & De Weid, D. (1981) Des-tyrosine-–endorphin in schizophrenia. Clinical, biochemical and hormonal aspects. Psychiatry Research, 5, 293310.
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Criteria for Evaluating Improvement in Schizophrenia in Psychopharmacological Research (With Special Reference to Gamma Endorphin Fragments)

  • Rahul Manchanda (a1), Steven R. Hirsch (a2) and Thomas R. E. Barnes (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *